Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05218174 · ClinicalTrials.gov registry record · NA
Exercise in Adults with Post-Acute Sequelae of SARS-CoV-2 (COVID-19) Infection Study
A NA study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05218174 is a NA study that has completed, run by Baylor Research Institute. The registered enrollment target is 21 participants.
The verdict
NCT05218174, a NA study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
To examine the efficacy of an 8-week exercise training program on functional, cognitive, and emotional health outcomes compared to a no treatment control condition in adults with PASC.
Interventions
- OTHER Exercise Prescription
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-04-22 |
| Est. Completion | 2023-12-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05218174
The ClinicalTrials.gov registry entry for NCT05218174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise Prescription is the first listed.
NCT05218174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05218174 about?
NCT05218174 is a clinical study titled "Exercise in Adults with Post-Acute Sequelae of SARS-CoV-2 (COVID-19) Infection Study". To examine the efficacy of an 8-week exercise training program on functional, cognitive, and emotional health outcomes compared to a no treatment control condition in adults with PASC.
What is the current status of trial NCT05218174?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2022-04-22. Estimated completion is 2023-12-29.
What interventions are being tested in trial NCT05218174?
The interventions under investigation include: Exercise Prescription (OTHER).
Who is sponsoring clinical trial NCT05218174?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.